 ##  [Abstract summaries for EULAR](/healthcare-professionals/medical-congresses-and-events/abstract-summaries-eular "Abstract summaries for EULAR") 

 Discover some of the scientific data we are presenting this year at the Annual European Congress of Rheumatology (EULAR) Virtual Congress 2021. These abstracts have been adapted into plain language summaries to help increase understanding of complex data. Please note that abstract summaries only contain information from the full scientific abstract and selected supporting references. The results of these studies may not reflect those of other studies. Summaries are not intended to provide medical advice nor intended for promotional use.

 

 ![EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-1.jpg.webp?itok=m88Roxjp "EULAR Abstract summaries preview") 

 

##  The effect of secukinumab on non-radiographic axial spondyloarthritis at 2 years 

A simplified overview of the abstract presented at EULAR June 2, 2021



 

 [Read More (PDF 0.3 MB)](/sites/novartis_com/files/effect-of-secukinumab-on-non-radiographic-axial-spondyloarthritis-at-2-years.pdf "Read More (PDF 0.3 MB)") 



 

 



 





 ![EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-2.jpg.webp?itok=pQ_K2jUX "EULAR Abstract summaries preview") 

 

##  Secukinumab effect across the axial spondyloarthritis spectrum at 1 year 

A simplified overview of the abstract presented at EULAR June 3, 2021.



 

 [Open summary (PDF 0.1 MB)](/sites/novartis_com/files/secukinumab-effect-across-the-axial-spondyloarthritis-spectrum-at-1-year.pdf "Open summary (PDF 0.1 MB)") 



 

 



 





 ![EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-3.jpg.webp?itok=St_tXWqC "EULAR Abstract summaries preview") 

 

##  Using sensitive ultrasound imaging to understand response of psoriatic arthritis to secukinumab over 24 weeks 

A simplified overview of the abstract presented at EULAR June 4, 2021.



 

 [Open summary (PDF 0.2 MB)](/sites/novartis_com/files/using-sensitive-ultrasound-imaging-to-understand-response-of-psoriatic-arthritis-to-secukinumab-over-24-weeks.pdf "Open summary (PDF 0.2 MB)") 



 

 



 





 ![EULAR Abstract summaries preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/abstract-summaries-for-eular-4.jpg.webp?itok=p32rCGNa "EULAR Abstract summaries preview") 

 

##  Secukinumab effect in two types of arthritis seen in children and adolescents at two years 

A simplified overview of the abstract presented at EULAR June 5, 2021.



 

 [Open summary (PDF 0.1 MB)](/sites/novartis_com/files/secukinumab-effect-in-two-types-of-arthritis-seen-in-children-and-adolescents-at-two-years.pdf "Open summary (PDF 0.1 MB)")